Live Birth Rate in Patients With Unexplained Recurrent Pregnancy Loss

Status Active, not recruiting

Clinical Trial Summary

STUDY AIM: to study the pregnancy outcomes and offspring development of patient with Unexplained Recurrent Pregnancy Loss Treated by PGS and spontaneous pregnancy, and to compare the health economic indicators and patient satisfaction of the two modes of pregnancy, so as to better guide the clinical treatment.

Clinical Trial Description

400 patients with two times or more unexplained pregnancy loss, who wants to be pregnant via preimplantation genetic screening procedure or spontaneous pregnancy are intended to be enrolled. They are going to divided into two groups: PGS(preimplantation genetic screening) group and SP(spontaneous pregnancy) group. The pregnancy outcomes and offspring development of those patients will be followed up by our investigators. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04621773
Study type	Observational [Patient Registry]
Source	Peking University Third Hospital
Contact
Status	Active, not recruiting
Phase
Start date	September 1, 2020
Completion date	September 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04718233` - Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss	Phase 2
Recruiting	`NCT01946945` - Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis	Phase 2
Completed	`NCT02572154` - Sperm DNA Fragmentation in Recurrent Pregnancy Loss	N/A
Completed	`NCT03174951` - Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss	Phase 2
Recruiting	`NCT05444283` - Genomic Predictors of Recurrent Pregnancy Loss
Recruiting	`NCT02990403` - The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss	Phase 4
Recruiting	`NCT02990390` - The Epidemiology of Recurrent Spontaneous Abortion Associated With Thrombophilla	N/A
Not yet recruiting	`NCT05612620` - Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss
Not yet recruiting	`NCT05520112` - Treatment of Recurrent Pregnancy Loss Using Mesenchymal Stem Cells	Phase 1/Phase 2
Suspended	`NCT04397042` - SCUBE-1 and Carotid Intima Media Thickness in Recurrent Pregnancy Loss
Not yet recruiting	`NCT05341856` - Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL	Early Phase 1
Recruiting	`NCT06007560` - Aerobe Cycling Training in Women With Unexplained Recurrent Pregnancy Loss	N/A
Completed	`NCT02386384` - TNFα and MFG-E8: Novel Biomarkers to Predict Implantation Failure	N/A
Recruiting	`NCT01635426` - Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages	Phase 2/Phase 3
Suspended	`NCT01546350` - Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH	Phase 2
Completed	`NCT00721591` - Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy	N/A
Terminated	`NCT00564174` - Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT	N/A
Completed	`NCT04455256` - Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss
Not yet recruiting	`NCT05237843` - Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss	Phase 1
Recruiting	`NCT02144064` - Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin	Phase 3